Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026)
Maxcyte's (MXCT) quarterly Amortizatization of Intangibles came in at $437000.0 in Q1 2026, down 50.57% year-on-year from $884000.0 in Q1 2025, and up 2.34% on a QoQ basis from $427000.0 in Q4 2025.
Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Amortizatization of Intangibles data on file, last reported at $437000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 50.57% year-over-year to $437000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 57.24% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 57.61% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $437000.0, up from $427000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for MXCT reached as high as $2.0 million in Q4 2023 and fell as low as $33200.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
- Across the five-year window, Amortizatization of Intangibles soared 5110.84% in 2023 and plunged 64.12% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.5 million in 2022, then jumped by 32.37% to $2.0 million in 2023, then slumped by 40.41% to $1.2 million in 2024, then sank by 64.12% to $427000.0 in 2025, then rose by 2.34% to $437000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $437000.0 in Q1 2026, $427000.0 in Q4 2025, and $584000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 437,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 751,000.00 |
| Jun 30, 2025 | 751,000.00 |
| Mar 31, 2025 | 884,000.00 |
| Mar 31, 2025 | 884,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |